Literature DB >> 10679386

Tumor suppressor genes.

K Macleod1.   

Abstract

Although tumor suppressor genes continue to be discovered, the most recent advances have been made in attributing new and exciting functions to existing ones - such as the apparent role of VHL as a regulator of proteolysis. Great insights have also come from piecing genes together into pathways and networks. For instance the discovery that cyclin D1 is regulated by beta-catenin/Tcf-4 allows us to tie the APC pathway to the RB pathway and cell cycle control. Similarly, tumor suppressor genes have been fitted together with oncogenes into the various pathways that regulate apoptosis such that tumor suppressor function is now attributed to some of the basic components of the apoptotic machinery, such as caspases and Apaf-1. The great pace at which mouse models of tumorigenesis continue to advance our knowledge of tumor suppressor gene function has led us to look anew at the role of genes such as TCF-1 and SMAD-3 in human cancer. Finally, the realisation that different growth regulatory pathways give rise to generic signals suggests that future work may lie in integrating the signals from different pathways and in understanding the importance of protein levels to cellular function.

Entities:  

Mesh:

Year:  2000        PMID: 10679386     DOI: 10.1016/s0959-437x(99)00041-6

Source DB:  PubMed          Journal:  Curr Opin Genet Dev        ISSN: 0959-437X            Impact factor:   5.578


  25 in total

Review 1.  Vitamin D and cancer: a review of molecular mechanisms.

Authors:  James C Fleet; Marsha DeSmet; Robert Johnson; Yan Li
Journal:  Biochem J       Date:  2012-01-01       Impact factor: 3.857

2.  Toxicity of depleted uranium complexes is independent of p53 activity.

Authors:  Ellie Heintze; Camille Aguilera; Malia Davis; Avery Fricker; Qiang Li; Jesse Martinez; Matthew J Gage
Journal:  J Inorg Biochem       Date:  2010-10-29       Impact factor: 4.155

3.  Jade-1, a candidate renal tumor suppressor that promotes apoptosis.

Authors:  Mina I Zhou; Rebecca L Foy; Vipul C Chitalia; Jin Zhao; Maria V Panchenko; Hongmei Wang; Herbert T Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-26       Impact factor: 11.205

4.  Survey of somatic mutations in tuberous sclerosis complex (TSC) hamartomas suggests different genetic mechanisms for pathogenesis of TSC lesions.

Authors:  Y Niida; A O Stemmer-Rachamimov; M Logrip; D Tapon; R Perez; D J Kwiatkowski; K Sims; M MacCollin; D N Louis; V Ramesh
Journal:  Am J Hum Genet       Date:  2001-07-20       Impact factor: 11.025

Review 5.  Biomarkers and the genetics of early neoplastic lesions.

Authors:  Sudhir Srivastava; William E Grizzle
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

6.  Lethality of Drosophila lacking TSC tumor suppressor function rescued by reducing dS6K signaling.

Authors:  Thomas Radimerski; Jacques Montagne; Maja Hemmings-Mieszczak; George Thomas
Journal:  Genes Dev       Date:  2002-10-15       Impact factor: 11.361

7.  TReP-132 controls cell proliferation by regulating the expression of the cyclin-dependent kinase inhibitors p21WAF1/Cip1 and p27Kip1.

Authors:  Florence Gizard; Romain Robillard; Olivier Barbier; Brigitte Quatannens; Anne Faucompré; Françoise Révillion; Jean-Philippe Peyrat; Bart Staels; Dean W Hum
Journal:  Mol Cell Biol       Date:  2005-06       Impact factor: 4.272

8.  The molecular genetics of breast cancer and targeted therapy.

Authors:  Rachel Suter; James A Marcum
Journal:  Biologics       Date:  2007-09

9.  Reduced succinate dehydrogenase B expression is associated with growth and de-differentiation of colorectal cancer cells.

Authors:  Decai Zhang; Wei Wang; Bo Xiang; Nan Li; Shuo Huang; Weiwei Zhou; Yingnan Sun; Xiaoyan Wang; Jian Ma; Guiyuan Li; Xiayu Li; Shourong Shen
Journal:  Tumour Biol       Date:  2013-05-05

10.  Timed somatic deletion of p53 in mice reveals age-associated differences in tumor progression.

Authors:  George Hinkal; Neha Parikh; Lawrence A Donehower
Journal:  PLoS One       Date:  2009-08-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.